KLK3 and metastatic neoplasm: The diagnostic sensitivity of choline-based PET tracers decreases notably at PSA levels below 2 ng/mL and becomes particularly limited when PSA falls below 1 ng/mL, reducing their effectiveness for detecting recurrent or metastatic disease in early biochemical relapse [11].